Los Angeles Capital Management LLC Concert Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 29, 2019	SELL	$9.44 - $13.12 $95,268 - $132,407	-10,092 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$12.07 - $17.54 $123,741 - $179,820	-10,252 Reduced 50.39%	10,092 $122,000
Q4 2018 Feb 11, 2019	SELL	$11.25 - $16.17 $384,592 - $552,787	-34,186 Reduced 62.69%	20,344 $255,000
Q3 2018 Nov 05, 2018	BUY	$12.82 - $17.88 $469,468 - $654,765	36,620 Added 204.47%	54,530 $809,000
Q2 2018 Jul 31, 2018	BUY	$16.83 - $21.66 $301,425 - $387,930	17,910 New	17,910 $301,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.